Conflombardia – Europa
Territori d’Europa
Tutti gli articoli
www.ema.europa.eu EMA staff will be joined on the boat by representatives of patient organisations such as EURORDIS-Rare Diseases Europe, European AIDS Treatment Group (EATG) and the European Patient Forum (EPF) to underline the commitment to collaboration and inclusion of diverse...
www.ema.europa.eu EMA’s Emergency Task Force (ETF) has recommended updating COVID-19 vaccines to target the new SARS-CoV-2 variant XFG for the 2026/2027 vaccination campaign. XFG is part of the JN.1 family of Omicron subvariants. Its circulation has increased worldwide since June 2025,...
www.ema.europa.eu CVMP opinions on veterinary medicinal products The Committee adopted a positive opinion for a marketing authorisation for Nobivac NXT HC, for the active immunisation of cats against feline herpesvirus type 1 and feline calicivirus. The Committee adopted a positive opinion...
www.ema.europa.eu Eight new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its May 2026 meeting. Jascayd (nerandomilast) received a positive opinion from the CHMP for the treatment of idiopathic pulmonary fibrosis (IPF)...
www.ema.europa.eu EMA has recommended granting a marketing authorisation in the European Union (EU) for Jascayd (nerandomilast) to treat adults with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF), two serious lung diseases that involve progressive and...
www.ema.europa.eu EMA’s office is closed on 25 May, to mark Whit Monday. The office reopens 08:30 on Tuesday, 26 May. The product emergency hotline is available outside working hours and on public holidays. To reach the emergency hotline, call +31 (0)88 781 7600. Please note that this is an...